Stephens Consulting, LLC Amneal Pharmaceuticals, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 45 shares of AMRX stock, worth $331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$331% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
208Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$109 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$90.7 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$83 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$78.9 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$66.1 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.11B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...